Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Posey · SciRah

Researcher profile · Semantic Scholar

J. Posey

Share profile

J. Posey — researcher profile on SciRah

h-index: 30
Works: 88
Citations: 4,256

Most-cited papers

Esophageal and esophagogastric junction cancers, version 1.2015.
J. Ajani, Thomas A. D'Amico, K. Almhanna, D. Bentrem +33 more
2015The Journal of the National Comprehensive Cancer Network465 citations
Semantic Scholar
Gastric Cancer, Version 2.2013
J. Ajani, D. Bentrem, S. Besh, Thomas A. D'Amico +27 more
2013425 citations
Semantic Scholar
Activity of sunitinib in patients with advanced neuroendocrine tumors.
M. Kulke, H. Lenz, N. Meropol, J. Posey +9 more
2008Journal of Clinical Oncology342 citations
Semantic Scholar
Esophageal and esophagogastric junction cancers.
J. Ajani, J. Barthel, D. Bentrem, Thomas A. D'Amico +25 more
2011The Journal of the National Comprehensive Cancer Network327 citations
Semantic Scholar
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.
J. Ajani, D. Bentrem, S. Besh, T. D'Amico +27 more
2013The Journal of the National Comprehensive Cancer Network321 citations
Semantic Scholar
Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5)
A. Forero-Torres, J. Shah, T. Wood, J. Posey +6 more
2010Cancer Biotherapy and Radiopharmaceuticals150 citations Open access
Semantic Scholar
Gastric cancer. Clinical practice guidelines in oncology.
J. Ajani, T. Bekaii-Saab, T. D'Amico, Charles S. Fuchs +18 more
2006The Journal of the National Comprehensive Cancer Network148 citations Open access
Semantic Scholar
A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.
J. Posey, T. Ng, Bao-Lian Yang, M. Khazaeli +5 more
2003Clinical Cancer Research128 citations
Semantic Scholar
Hepatobiliary cancers, version 2.2014.
A. Benson, M. D'Angelica, Thomas A. Abrams, C. Are +24 more
2014The Journal of the National Comprehensive Cancer Network125 citations Open access
Semantic Scholar
Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity
Wen W. Ma, M. Saif, B. El-Rayes, M. Fakih +5 more
2016Cancer117 citations Open access
Semantic Scholar
Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis
Q. Wei, Z. Ye, Xue Zhong, Ling Li +16 more
2017Annals of Oncology110 citations Open access
Semantic Scholar
Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).
G. Abou-Alfa, Donna Niedzwieski, J. Knox, A. Kaubisch +16 more
2016110 citations
Semantic Scholar
Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer.
J. Berlin, J. Posey, S. Tchekmedyian, E. Hu +5 more
2007Clinical colorectal cancer110 citations
Semantic Scholar
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.
G. Abou-Alfa, Q. Shi, J. Knox, A. Kaubisch +23 more
2019JAMA Oncology105 citations Open access
Semantic Scholar
A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.
J. Posey, M. Khazaeli, M. Bookman, A. Nowrouzi +8 more
2002Clinical Cancer Research105 citations
Semantic Scholar
Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer.
R. Hines, C. Chatla, H. Bumpers, J. Waterbor +5 more
2009Journal of Clinical Oncology95 citations Open access
Semantic Scholar
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long‐term survival and reveals a role for ANGPTL4
Marie K. Kirby, R. Ramaker, J. Gertz, Nicholas S. Davis +12 more
2016Molecular Oncology94 citations Open access
Semantic Scholar
Effect of Comorbidity and Body Mass Index on Colon Cancer Survival of African American and Caucasian Patients
R. Hines, Chandrakumar Shanmugam, J. Waterbor, G. McGwin +4 more
2009Cancer78 citations Open access
Semantic Scholar
A phase 2 study to evaluate the efficacy and safety of SU11248 in patients (pts) with unresectable neuroendocrine tumors (NETs)
M. Kulke, H. Lenz, N. Meropol, J. Posey +6 more
200572 citations
Semantic Scholar
Resectability of Pancreatic Adenocarcinoma in Patients with Locally Advanced Disease Downstaged by Preoperative Therapy: A Challenge for MDCT
D. Morgan, Clinton N. Waggoner, C. Canon, M. Lockhart +3 more
2010AJR. American journal of roentgenology71 citations Open access
Semantic Scholar
NCCN Practice Guidelines for Colorectal Cancer.
Al B. Benson, M. Choti, A. Cohen, J. Doroshow +9 more
2000Oncology66 citations
Semantic Scholar
Abemaciclib is effective against pancreatic cancer cells and synergizes with HuR and YAP1 inhibition
T. Dhir, Christopher W. Schultz, Aditi Jain, Samantha Z. Brown +11 more
2019Molecular Cancer Research51 citations Open access
Semantic Scholar
Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas
J. Posey, M. Saif, R. Carlisle, A. Goetz +8 more
2005Clinical Cancer Research51 citations Open access
Semantic Scholar
Bax expression is a candidate prognostic and predictive marker of colorectal cancer.
V. Katkoori, Catalina Suarez-Cuervo, Chandrakumar Shanmugam, N. Jhala +7 more
2010Journal of Gastrointestinal Oncology49 citations
Semantic Scholar
Use of non-ionizing electromagnetic fields for the treatment of cancer.
Hugo Jimenez, C. Blackman, G. Lesser, W. Debinski +15 more
2018Frontiers in Bioscience40 citations
Semantic Scholar
Racial Disparities in Rates of Surgery for Esophageal Cancer: a Study from the National Cancer Database
Samantha L. Savitch, T. Grenda, W. Scott, S. Cowan +5 more
2020Journal of Gastrointestinal Surgery35 citations
Semantic Scholar
Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study
M. Dobelbower, S. Russo, K. P. Raisch, Leisa L. Seay +4 more
2006Anti-Cancer Drugs35 citations
Semantic Scholar
Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventions
A. Arthur, Ashley Delk, W. Demark-Wahnefried, J. Christein +5 more
2016Journal of cancer survivorship34 citations Open access
Semantic Scholar
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response
A. Lamarca, J. Barriuso, M. Kulke, I. Borbath +8 more
2017British Journal of Cancer31 citations Open access
Semantic Scholar
Esophageal and Esophagogastric Junction Cancers Clinical Practice Guidelines in Oncology
M. Orringer, R. Osarogiagbon, J. Posey, A. Sasson +24 more
201130 citations
Semantic Scholar
Results of a phase 2/3 open-label, randomized trial of T138067 versus doxorubicin (DOX) in chemotherapy-naïve, unresectable hepatocellular carcinoma (HCC).
J. Posey, P. Johnson, T. Mok, M. Hirmand +3 more
200530 citations
Semantic Scholar
A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas
M. Saleh, I. Percent, T. Wood, J. Posey +4 more
200828 citations Open access
Semantic Scholar
Gastric Cancer Clinical Practice Guidelines.
J. Ajani, T. Bekaii-Saab, T. D'Amico, C. Fuchs +18 more
2006The Journal of the National Comprehensive Cancer Network27 citations
Semantic Scholar
Esophageal Cancer Clinical Practice Guidelines.
J. Ajani, T. Bekaii-Saab, T. D'Amico, C. Fuchs +18 more
2006The Journal of the National Comprehensive Cancer Network27 citations Open access
Semantic Scholar
Gastroesophageal Junction Adenocarcinoma: Is There an Optimal Management?
Daniel Lin, U. Khan, T. Goetze, Natalie Reizine +5 more
2019American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting26 citations
Semantic Scholar
Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging
Hyunki Kim, P. Arnoletti, J. Christein, M. Heslin +4 more
2014Abdominal Imaging24 citations
Semantic Scholar
Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
Aileen Deng, Chun Wang, S. J. Cohen, J. Winter +3 more
2021European Journal of Cancer19 citations
Semantic Scholar
Quantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: a pilot study.
Hyunki Kim, K. Keene, D. Sarver, S. K. Lee +3 more
2014Gastrointestinal cancer research : GCR19 citations
Semantic Scholar
A phase II study of IMGN242 (huC242-DM4) in patients with CanAg-positive gastric or gastroesophageal (GE) junction cancer.
L. Goff, K. Papadopoulos, J. Posey, A. Phan +6 more
2009Journal of Clinical Oncology16 citations
Semantic Scholar
A phase I trial of RX-0201 (AKT anti-sense) in patients with an advanced cancer
J. Marshall, J. Posey, Jimmy J. Hwang, S. Malik +6 more
200716 citations
Semantic Scholar
Second-line treatment for metastatic pancreatic cancer.
R. Paluri, A. Kasi, C. Young, J. Posey
2020Clinical advances in hematology & oncology : H&O15 citations
Semantic Scholar
A comparison of 12-gene colon cancer assay gene expression in African American and Caucasian patients with stage II colon cancer
R. Govindarajan, J. Posey, C. Chao, R. Lu +6 more
2016BMC Cancer12 citations Open access
Semantic Scholar
Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers
A. Dowlati, J. Posey, R. Ramanathan, Linda Rath +8 more
2009Cancer Chemotherapy and Pharmacology10 citations Open access
Semantic Scholar
Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone
A. McDonald, C. Dulaney, J. López-Araujo, J. Posey +5 more
2015Journal of Gastrointestinal Cancer8 citations
Semantic Scholar
Vanderbilt-Ingram Cancer Center
C. Wright, Debra Zelman, L. Kleinberg, S. Leong +4 more
20148 citations Open access
Semantic Scholar
Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA.
Daniel Lin, Rui Luo, Z. Ye, Q. Wei +5 more
2023Clinics And Research in Hepatology and Gastroenterology6 citations
Semantic Scholar
Clinical trial experience with uridine triacetate for 5-fluorouracil toxicity.
Wen W. Ma, W. Saif, B. El-Rayes, M. Fakih +4 more
20166 citations
Semantic Scholar
Phase I study of RX-0201 in patients with advanced or metastatic solid tumors.
S. Malik, Jimmy Hwang, John L. Marshall, Pari Ramzi +3 more
2006Journal of Clinical Oncology6 citations
Semantic Scholar
A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution’s experience
Cinthya Y Lowder, T. Dhir, Austin B. Goetz, Henry L Thomsett +11 more
2020Surgical oncology4 citations Open access
Semantic Scholar
A Routine Laboratory Data-Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer.
Z. Ye, Chun Wang, Limin Guo, J. Palazzo +8 more
2018The Journal of the National Comprehensive Cancer Network4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Orringer×9
Invite
M. Orringer — researcher profile on SciRah
A. Sasson×9
Invite
A. Sasson — researcher profile on SciRah
C. Fuchs×8
Invite
C. Fuchs — researcher profile on SciRah
J. Hayman×8
Invite
J. Hayman — researcher profile on SciRah

×6

Invite

N. Meropol — researcher profile on SciRah

R. Osarogiagbon×6

Invite

R. Osarogiagbon — researcher profile on SciRah

Invite

D. Bentrem — researcher profile on SciRah

Invite

P. Das — researcher profile on SciRah

C. Denlinger×5

Invite

C. Denlinger — researcher profile on SciRah

Invite

R. Glasgow — researcher profile on SciRah

Invite

R. Keswani — researcher profile on SciRah

Invite

W. Korn — researcher profile on SciRah